Diabetes in Pregnancy Study Group of North America

The Diabetes in Pregnancy Study Group of North America (DPSG-NA) was founded in 1997 out of the recognition that the field of maternal-fetal medicine should support and conduct research to address the specialized needs of pregnant women with type 1, type 2 or gestational diabetes mellitus.

Since its inception, the DPSG-NA membership has expanded beyond maternal-fetal medicine specialists to include endocrinologists, obstetricians and gynecologists, nurses, nurse practitioners, physicians’ assistants, midwives, diabetes educators, geneticists, pediatricians, internists, fellows, medical students and basic research scientists with an interest in diabetes or diabetes in pregnancy.

Collaboration between basic, translational, and clinical researchers and care centers, both in the United States and abroad, has occurred through annual and biennial meetings. From 2005 to the present, these meetings have been hosted in Washington, DC.

In 2017, the University of Maryland School of Medicine became the academic home of the DPSG-NA.

Learning Objectives

• Evaluate the pros and cons of prevention strategies to reduce the incidence of diabetes before, during and after pregnancy
• Identify patients at highest risk for pregnancy complications by recognizing the mechanisms that lead to adverse maternal and neonatal outcomes
• Identify patients at higher risk for adverse pregnancy outcomes due to obesity complications and adjust care during the preconception period and gestation
• Identify tools to modify risk factors in the postpartum period to reduce incidence of or complications from diabetes
• Discuss interventions to reduce risks due to hypertension in pregnancy, including preeclampsia
• Recognize the social determinants of health in caring for patients at high risk for pregnancy complications due to comorbidities or health disparities

Target Audience

The Biennial Meetings of the Diabetes in Pregnancy Study Group of North America (DPSG-NA) is intended for all healthcare professionals and biomedical researchers with a special interest in the treatment of pregnant women with diabetes.